MANIPALHOSManipal Health Enterprises Ltd.
Manipal Health Enterprises Q2 FY27 Results: Consolidated Net Profit ₹285 Crore on Total Income of ₹3,499 Crore
- Earnings
- hospitals and healthcare services

Manipal Health Enterprises (NSE: MANIPALHOS) reported consolidated total income of ₹3,499.08 crore and consolidated net profit of ₹284.98 crore for the quarter ended 30 Sep 2026, it said in a filing on 13 Nov 2026. Standalone total income was ₹1,249.76 crore and standalone net profit ₹164.51 crore.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹3,499.08 crore, up 38.7% YoY and 10.5% QoQ
- Net profit and EPS: ₹284.98 crore, down 10.3% YoY and up 17.1% QoQ; basic EPS ₹2.14
- Exceptional items: ₹95.18 crore, including a ₹79.70 crore NCD prepayment fee
- Finance costs: ₹300.11 crore, up 92.3% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹1,249.76 crore, up 34.6% YoY and 14.7% QoQ
- Net profit and EPS: ₹164.51 crore, up 26.6% YoY and 42.4% QoQ; basic EPS ₹1.31
- Other income: ₹98.63 crore, up 270.2% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 3,499.08 | 2,523.38 | +38.7% | 3,165.19 | +10.5% | |
| Revenue from operations | 3,399.35 | 2,475.42 | +37.3% | 3,090.63 | +10.0% |
| Other income | 99.73 | 47.96 | +107.9% | 74.56 | +33.8% |
| 284.98 | 317.78 | -10.3% | 243.43 | +17.1% | |
| Profit before tax | 371.56 | 417.79 | -11.1% | 315.18 | +17.9% |
| Finance costs | 300.11 | 156.07 | +92.3% | 293.27 | +2.3% |
| Depreciation | 204.87 | 150.85 | +35.8% | 187.25 | +9.4% |
| Tax expense | 86.58 | 100.01 | -13.4% | 71.75 | +20.7% |
| Net profit margin | 8.14% | 12.59% | -4.45 pp | 7.69% | +0.45 pp |
| EPS, basic (₹) | 2.14 | 2.69 | -20.4% | 1.96 | +9.2% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated total income rose 38.7% YoY, but net profit fell 10.3% to ₹284.98 crore from ₹317.78 crore a year earlier. Profit before tax fell 11.1%, and the tax expense fell 13.4%, so the gap between the two was mainly in the pre-tax line.
Finance costs of ₹300.11 crore were 8.6% of total income this quarter, against ₹156.07 crore a year earlier, when they were about 6.2% of total income. Depreciation rose 35.8% to ₹204.87 crore. The filing does not explain the reasons for the rise in finance costs and depreciation.
Other income of ₹99.73 crore is 26.8% of consolidated profit before tax of ₹371.56 crore. The filing records ₹95.18 crore of exceptional items in the quarter, including a one-time prepayment fee of ₹79.70 crore on the redemption of NCDs of subsidiary MHPL, repaid from IPO proceeds of ₹5,874.45 crore including interest. Net profit attributable to owners was ₹269.79 crore, against ₹284.98 crore for the period before minority interests.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 1,249.76 | 928.28 | +34.6% | 1,089.17 | +14.7% | |
| Revenue from operations | 1,151.13 | 901.64 | +27.7% | 1,048.30 | +9.8% |
| Other income | 98.63 | 26.64 | +270.2% | 40.87 | +141.3% |
| 164.51 | 129.91 | +26.6% | 115.53 | +42.4% | |
| Profit before tax | 219.51 | 163.98 | +33.9% | 151.76 | +44.6% |
| Finance costs | 65.06 | 45.11 | +44.2% | 61.59 | +5.6% |
| Depreciation | 77.30 | 53.05 | +45.7% | 64.14 | +20.5% |
| Tax expense | 55.00 | 34.07 | +61.4% | 36.23 | +51.8% |
| Net profit margin | 13.16% | 13.99% | -0.83 pp | 10.61% | +2.56 pp |
| EPS, basic (₹) | 1.31 | 1.12 | +17.0% | 0.98 | +33.7% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone total income rose 34.6% YoY and net profit rose 26.6% to ₹164.51 crore. Revenue from operations rose 27.7%, while other income rose from ₹26.64 crore to ₹98.63 crore, so other income made up 7.9% of standalone total income this quarter.
Standalone finance costs of ₹65.06 crore are 5.2% of total income, up 44.2% YoY. Standalone exceptional items were ₹14.00 crore, the amortised portion of a discretionary one-time employee incentive agreed in the quarter ended 31 Mar 2026. Standalone other income of ₹98.63 crore is 44.9% of standalone profit before tax of ₹219.51 crore.
Inference
The company completed an IPO in the quarter of 157,233,715 equity shares at ₹590.00 per share, comprising a fresh issue of 135,619,881 shares aggregating ₹8,000 crore and an offer for sale of 21,613,834 shares aggregating ₹1,275 crore. The shares were listed on NSE and BSE on 5 Aug 2026. The filing does not say how the remaining IPO proceeds will be used.
The filing records a ₹495.00 crore Juhu land and building acquisition, of which ₹130.00 crore is payable subject to conditions, and a ₹130.00 crore Kinder Women's Hospital business transfer, of which ₹10.00 crore is payable subject to a condition subsequent. The filing does not state when these balances will be paid.
After the period, the company entered a 29 years 11 months lease deed for land in Gurugram, Haryana, for a greenfield tertiary care hospital. Consolidated results include Sahyadri Hospitals Private Limited, a controlling stake acquired from 3 Oct 2025 for ₹4,596.55 crore, with a commitment to acquire a further 9.84% on 1 Dec 2026.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.


